Hilton Orlando, Florida Ballroom 1-4 | Supported By: An educational grant from AstraZeneca.

---

Program Description

Join us for this live educational symposium that brings interleukin (IL)-33, an emerging therapeutic target in respiratory medicine, to center stage. This program will examine the evolving role of IL-33 as both a driver of inflammation and a regulator of gene expression, highlighting its signaling pathways and contribution to the pathophysiology of chronic respiratory disease and acute infection. Attendees will gain insight into the scientific rationale for targeting IL-33 in therapeutic development, along with the latest updates from ongoing clinical investigations of biologic agents designed to modulate its activity. Our expert panel will share their perspectives through dynamic discussion and real-time engagement with the audience.

This program was developed by, or with financial support and influence from, Integritas Communications and is neither sponsored by nor endorsed by ATS.

There is no fee to attend this educational program; however, seating is limited. Preregistration does not guarantee seating. We recommend arriving at the symposium location early.

Speakers

Panelist: Jonathan M. Hand, MD, FIDSA, FAST
The University of Queensland School of Medicine – Ochsner Health
Associate Professor of Medicine
New Orleans
Louisiana

Panelist: Tom Wilkinson, MA Cantab, MBBS, PhD, FRCP, FERS
University of Southampton
Professor of Respiratory Medicine and Associate Dean Faculty of Medicine
United Kingdom
Southampton

University Hospital Southampton NHS Foundation Trust
Honorary Consultant
United Kingdom
Southampton

National Institute for Health and Care Research; National Respiratory Audit Programmer
Senior Investigator; Senior Clinical Lead
United Kingdom
Southampton

Panelist: Dave Singh, MD, FERS, FBPhS
University of Manchester
Professor of Clinical Pharmacology and Respiratory Medicine
United Kingdom
London

Medicines Evaluation Unit, an IQVIA business
Medical Director
United Kingdom
London

Manchester University Foundation Hospitals Trust
Honorary Respiratory Consultant
United Kingdom
London